Potential short-term economic benefits of improved glycemic control: a managed care perspective.
about
The association between diabetes related medical costs and glycemic control: a retrospective analysis.Effectiveness of pharmacist-administered diabetes mellitus education and management servicesEconomic Value of Improved Accuracy for Self-Monitoring of Blood Glucose Devices for Type 1 Diabetes in Canada.Treatment satisfaction in people with type 2 diabetes mellitus treated with once-weekly dulaglutide: data from the AWARD-1 and AWARD-3 clinical trials.Patient treatment satisfaction after switching to NovoMix® 30 (BIAsp 30) in the IMPROVE™ study: an analysis of the influence of prior and current treatment factors.Early diagnosis of left ventricular diastolic dysfunction in diabetic patients: a possible role for natriuretic peptides.Cost effectiveness and cost utility of the noncoding blood glucose meter CONTOUR TSAn overview of management issues in adult patients with type 2 diabetes mellitus.Differential adoption of pharmacotherapy recommendations for type 2 diabetes by generalists and specialists.Examining correlates of treatment satisfaction for injectable insulin in type 2 diabetes: lessons learned from a clinical trial comparing biphasic and basal analoguesHow poorer quality of life in adolescence predicts subsequent type 1 diabetes management and control.Psychometric properties of the Greek Diabetes Treatment Satisfaction QuestionnaireRandomised controlled trial of near-patient testing for glycated haemoglobin in people with type 2 diabetes mellitus.Selecting an A1C Point-of-Care InstrumentMultisystemic therapy compared to telephone support for youth with poorly controlled diabetes: findings from a randomized controlled trialAdherence to Oral Antihyperglycemic Agents Among Older Adults With Mental Disorders and Its Effect on Health Care Costs, Quebec, Canada, 2005-2008.Impact of inpatient diabetes management, education, and improved discharge transition on glycemic control 12 months after discharge.Early treatment revisions by addition or switch for type 2 diabetes: impact on glycemic control, diabetic complications, and healthcare costs.Glycemic control and diabetes-related health care costs in type 2 diabetes; retrospective analysis based on clinical and administrative databases.The effects of quality of care on costs: a conceptual frameworkDisentangling the roles of parental monitoring and family conflict in adolescents' management of type 1 diabetesMaintaining physiological state for exceptional survival: What is the normal level of blood glucose and does it change with age?Ascensia WinGLUCOFACTS Professional Software improves diabetes health outcomes.Association Between Sustained Glycated Hemoglobin Control and Healthcare Costs.The impact of diabetes counseling and education: clinical and cost outcomes from a large population of US managed care patients with type 2 diabetes.The future of diabetes education: expanded opportunities and roles for diabetes educators.Type 2 Diabetes Mellitus Patients' Healthcare Costs Related to Inpatient Hospitalizations: A Retrospective Administrative Claims Database Study.Barriers to diabetes education in urban patients: perceptions, patterns, and associated factors.Regional, Geographic, and Ethnic Differences in Medication Adherence Among Adults with Type 2 Diabetes.A novel approach to optimise glycaemic control in insulin users.Synchronous provider visit and self-management education improves glycemic control in Hispanic patients with long-standing type 2 diabetes.Providing diabetes education and care to underserved patients in a collaborative practice at a utah community health center.Direct medical costs for type 2 diabetes mellitus complications in the US commercial payer setting: a resource for economic research.Health outcomes and economic impact of therapy conversion to a biphasic insulin analog pen among privately insured patients with type 2 diabetes mellitus.Diabetes inpatients: a case of lose, lose, lose. Is it time to use a 'diabetes-attributable hospitalization cost' to assess the impact of diabetes?Insulin therapy for type 2 diabetes - are we there yet? The d-Nav® story.Economic Value of Improved Accuracy for Self-Monitoring of Blood Glucose Devices for Type 1 and Type 2 Diabetes in England
P2860
Q25255574-E3DFB767-F0AA-49F3-8075-194704FCC7E2Q28193521-3EFAF8D7-CB6E-4AC9-A912-2B5BFD13F787Q30278856-E3A7BA53-2B30-4FD6-9C4D-C9FF3E01357DQ30975622-382700A0-C3C4-43A5-9004-E6D6408728C8Q34238821-BB070C18-808B-47F9-94D7-B044CF5D1187Q34481884-F2AA6091-1719-486D-91E1-F252502F6443Q34721258-BAB69383-DCBB-47E9-AEBF-9489D854E55EQ35075959-7943245F-6BE3-43DB-892D-CA02CDBC3817Q35151533-14B53AA2-63D8-488C-8DFD-11C7E381C4BCQ35647028-DBA752F1-BC57-4EF4-9BA2-E54540C3076CQ35742920-91F017B2-720B-4A3A-9E7A-A449E449D433Q35799908-5E56446C-8CEC-4C49-B410-33C4F73547CAQ35800964-4E043372-9F92-4E33-863E-BF6729AF154FQ35953862-9505CBCF-35ED-424F-B229-E969126AADE8Q36236701-00D2B626-D1D0-4475-A0DC-7AF344E068D3Q36426092-924CAF80-9F33-4D80-8078-2399F42A3BDEQ36445913-0016866A-9C0B-4D62-BE3F-DB1FA1A28BFBQ36602531-C9A9DE92-2539-4ACF-913C-6739DAA01B03Q36857207-180409A0-0C3D-4E33-B6A8-950846519D84Q36965504-47A49ECB-5E5C-40B8-B37A-40B6D12647AFQ37263035-182D5B12-76C1-43EE-BBF9-18A6F480D0C4Q37393450-068A9398-4451-4F6F-B747-F838475460A3Q37403931-A84CA798-AF44-498E-BD4F-AC30774B262AQ37417227-1FC833D2-F78B-4CCA-B562-F9049C72422EQ38103776-7084CBAE-0BEF-49F1-AA3D-F04FC8E84E8CQ38104666-7ABAA219-9F84-46F4-8480-F50ACCCC2EA1Q38550932-8AC8A405-B2AA-4556-8202-DA8291A49A41Q39718186-C6A738A7-A929-42D5-BB62-C0B7A88834FFQ39970034-EC290D1F-710F-4CAA-BD18-B0E7A2C6E94CQ41905403-E9F73D33-2D57-49FE-9F4D-1066D3FE967CQ46058884-CD05411D-90AF-47ED-BF77-8F09509E8982Q46378373-DB52AA06-EBA5-47A7-9A45-F28F671F194CQ46886667-BCCCADD5-9FC3-4B36-9DFA-BEB3A9F9EF60Q50969719-E1FAF7F3-5DD9-47BC-A02D-70C62D4CDB5FQ51160796-835FDF4B-DCC6-415E-A8CF-C3946F372E71Q55116866-1226C148-88D6-448F-94B3-7EC3B89D5F24Q56380088-35452F24-48BC-45C8-8015-D27AFAA93E1D
P2860
Potential short-term economic benefits of improved glycemic control: a managed care perspective.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Potential short-term economic ...... l: a managed care perspective.
@ast
Potential short-term economic ...... l: a managed care perspective.
@en
type
label
Potential short-term economic ...... l: a managed care perspective.
@ast
Potential short-term economic ...... l: a managed care perspective.
@en
prefLabel
Potential short-term economic ...... l: a managed care perspective.
@ast
Potential short-term economic ...... l: a managed care perspective.
@en
P2093
P356
P1433
P1476
Potential short-term economic ...... l: a managed care perspective.
@en
P2093
Boulanger L
Cavanaugh R
Friedman M
Langley-Hawthorne C
P356
10.2337/DIACARE.24.1.51
P407
P577
2001-01-01T00:00:00Z